6.
Kanis J, Black D, Cooper C, dArgent P, Dawson-Hughes B, De Laet C
. A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int. 2002; 13(7):527-36.
DOI: 10.1007/s001980200069.
View
7.
Kanis J, Oden A, McCloskey E, Johansson H, Wahl D, Cooper C
. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012; 23(9):2239-56.
PMC: 3421108.
DOI: 10.1007/s00198-012-1964-3.
View
8.
Oden A, McCloskey E, Johansson H, Kanis J
. Assessing the impact of osteoporosis on the burden of hip fractures. Calcif Tissue Int. 2012; 92(1):42-9.
DOI: 10.1007/s00223-012-9666-6.
View
9.
Sanchez-Riera L, Carnahan E, Vos T, Veerman L, Norman R, Lim S
. The global burden attributable to low bone mineral density. Ann Rheum Dis. 2014; 73(9):1635-45.
DOI: 10.1136/annrheumdis-2013-204320.
View
10.
Kaptoge S, da Silva J, Brixen K, Reid D, Kroger H, Nielsen T
. Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on Male Osteoporosis (NEMO) study. Bone. 2008; 43(2):332-339.
DOI: 10.1016/j.bone.2008.04.001.
View
11.
Hui S, Slemenda C, JOHNSTON Jr C
. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 1988; 81(6):1804-9.
PMC: 442628.
DOI: 10.1172/JCI113523.
View
12.
Kanis J, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B
. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int. 2002; 12(12):989-95.
DOI: 10.1007/s001980170006.
View
13.
Kanis J, Oden A, Johnell O, Johansson H, De Laet C, Brown J
. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007; 18(8):1033-46.
DOI: 10.1007/s00198-007-0343-y.
View
14.
Kanis J, McCloskey E, Branco J, Brandi M, Dennison E, Devogelaer J
. Goal-directed treatment of osteoporosis in Europe. Osteoporos Int. 2014; 25(11):2533-43.
DOI: 10.1007/s00198-014-2787-1.
View
15.
Kanis J, Johansson H, Harvey N, McCloskey E
. A brief history of FRAX. Arch Osteoporos. 2018; 13(1):118.
PMC: 6290984.
DOI: 10.1007/s11657-018-0510-0.
View
16.
De La Sierra A
. New American and European Hypertension Guidelines, Reconciling the Differences. Cardiol Ther. 2019; 8(2):157-166.
PMC: 6828883.
DOI: 10.1007/s40119-019-0144-3.
View
17.
Kanis J, McCloskey E, Harvey N, Cooper C, Rizzoli R, Dawson-Hughes B
. The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis. Osteoporos Int. 2022; 34(1):1-9.
DOI: 10.1007/s00198-022-06567-9.
View
18.
Kanis J, Harvey N, Cooper C, Johansson H, Oden A, McCloskey E
. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos. 2016; 11(1):25.
PMC: 4978487.
DOI: 10.1007/s11657-016-0278-z.
View
19.
Messina O, Vidal M, Torres J, Vidal L, Arguissain C, Pereira R
. Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 update : This manuscript has been produced under the auspices of the Committee of.... Aging Clin Exp Res. 2022; 34(11):2591-2602.
DOI: 10.1007/s40520-022-02261-2.
View
20.
Veronese N, Briot K, Guanabens N, Albergaria B, Alokail M, Al-Daghri N
. Recommendations for the optimal use of bone forming agents in osteoporosis. Aging Clin Exp Res. 2024; 36(1):167.
PMC: 11315730.
DOI: 10.1007/s40520-024-02826-3.
View